The long journey from cell culture to a purified monoclonal antibody (mAb) involves many sample processing steps, with clarification and filtration playing significant roles. However, clogs, complex ...

Many early workflows lack scalability, relying on temperature-sensitive steps, outdated purification tools or unnecessary customization. These design flaws often derail timelines and inflate costs ...

Platform processes and effective risk assessments help overcome time and cost challenges. Successful biomanufacturing processes not only provide the desired product in high yield and purity, they ...

A novel continuous monoclonal antibody (mAb) production process could help drug firms reach quality goals and cope with changing capacity needs, according to CDMO Fujifilm Diosynth Biotechnologies.

Monoclonal antibody and viral vector manufacture share similarities, but vector scale up faces unique challenges. Scale up in gene therapy manufacturing currently revolves around viral vector scale up ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...

Therapeutic antibodies will always be too expensive for low- and middle-income countries, unless manufacturers embrace more cost-efficient production tech. So says Peter Gardner, scientific director ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...